TCL Archive Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial December 25, 2009
TCL Archive Senate Subcommittee Oks $850Million for Cancer; NCI Reveals How It Would Spend Fiscal 1978 Funds June 18, 1976